A mathematical model of idiopathic pulmonary fibrosis

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Hao, Wenrui ^a   Marsh, Clay ^b   Friedman, Avner ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; INTERLEUKIN 13; LEBRIKIZUMAB; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PIRFENIDONE; PLATELET DERIVED GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TRALOKINUMAB; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; MACROPHAGE; MATHEMATICAL MODEL; MATHEMATICAL PARAMETERS; MYOFIBROBLAST; SCAR; SIMULATION; VALIDATION STUDY; DISEASE COURSE; DRUG EFFECTS; DRUG INTERACTION; EPITHELIUM; IDIOPATHIC PULMONARY FIBROSIS; INFLAMMATION; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; PATHOLOGY; PATHOPHYSIOLOGY; THEORETICAL MODEL; UNITED STATES; WOUND HEALING;

DISEASE PROGRESSION; DRUG INTERACTIONS; EPITHELIUM; FIBROBLASTS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INFLAMMATION; MACROPHAGES, ALVEOLAR; MODELS, THEORETICAL; PULMONARY ALVEOLI; UNITED STATES; WOUND HEALING;

EID: 84944312712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135097     Document Type: Article

References (59)

1. Selman M, Pardo A. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model. Am J RespirCritCare Med. 2014 May; 189(10):1161-1172. doi: 10.1164/rccm.201312-2221PP PMID: 24641682
2. Bargagli E, Prasse A, Olivieri C, Muller-Quernheim J, Rottoli P. Macrophage-derived biomarkers of idiopathic pulmonary fibrosis. Pulm Med. 2011;2011:717130. doi: 10.1155/2011/717130 PMID: 21637368
3. WNP. Epithelial fibroblast triggering and interactions in pulmonary fibrosis. Eur Respir Rev. 2008 May; 17(109):123-129. doi: 10.1183/09059180.00010904
4. Daniil ZD, Papageorgiou E, Koutsokera A, Kostikas K, Kiropoulos T, Papaioannou AI, et al. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther. 2008;21(1):26-31. doi: 10.1016/j.pupt.2006.10.005 PMID: 17161968
5. Kliment CR, Oury TD. Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis. Free Radic Biol Med. 2010 Sep; 49(5):707-717. doi: 10.1016/j.freeradbiomed.2010.04.036 PMID: 20452419
6. Camelo A, Dunmore R, Sleeman MA, Clarke DL. The epithelium in idiopathic pulmonary fibrosis: breaking the barrier. Front Pharmacol. 2014 Jan; 4:173. doi: 10.3389/fphar.2013.00173 PMID: 24454287
7. Herzog EL, Bucala R., Fibrocytes in health and disease., Exp Hematol. 2010 Jul; 38(7):548-556. doi: 10.1016/j.exphem.2010.03.004 PMID: 20303382
8. Malli F, Koutsokera A, Paraskeva E, Zakynthinos E, Papagianni M, Makris D, et al., Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept., PLoS ONE. 2013;8(1):e53658. doi: 10.1371/journal.pone.0053658 PMID: 23341966
9. Bringardner BD, Baran CP, Eubank TD, Marsh CB., The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis., Antioxid Redox Signal. 2008 Feb; 10(2):287-301. doi: 10.1089/ars.2007. 1897 PMID: 17961066
10. Homer RJ, Elias JA, Lee CG, Herzog E., Modern concepts on the role of inflammation in pulmonary fibrosis., Arch Pathol Lab Med. 2011 Jun; 135(6):780-788. PMID: 21631273
11. Zoz DF, Lawson WE, Blackwell TS., Idiopathic pulmonary fibrosis: a disorder of epithelial cell dysfunction., Am J MedSci. 2011 Jun; 341(6):435-438. doi: 10.1097/MAJ.0b013e31821a9d8e PMID: 21613930
12. Boorsma CE, Draijer C, Melgert BN., Macrophage heterogeneity in respiratory diseases., Mediators Inflamm. 2013;2013:769214. doi: 10.1155/2013/769214 PMID: 23533311
13. McRitchie DI, Isowa N, Edelson JD, Xavier AM, Cai L, et al., Production of tumour necrosis factor alpha by primary cultured rat alveolar epithelial cells., Cytokine. 2000 Jun; 12(6):644-654. doi: 10.1006/cyto. 1999.0656 PMID: 10843740
14. Iyonaga K, Takeya M, Saita N, Sakamoto O, Yoshimura T, Ando M, et al., Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases., Hum Pathol. 1994 May; 25(5):455-463. doi: 10.1016/0046-8177 (94) 90117-1 PMID: 8200639
15. Selman M, Pardo A., Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers., ProcAmThoracSoc. 2006 Jun; 3(4):364-372. doi: 10.1513/pats.200601-003TK PMID: 16738202
16. Landsman L, Jung S., Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages., J Immunol. 2007 Sep; 179(6):3488-3494. doi: 10.4049/jimmunol.179.6. 3488 PMID: 17785782
17. Stahl M, Schupp J, Jager B, Schmid M, Zissel G, Muller-Quernheim J, et al., Lungcollagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation., PLoS ONE. 2013;8(11):e81382. doi: 10. 1371/journal.pone.0081382 PMID: 24278429
18. Pechkovsky DV, Prasse A, Kollert F, Engel KM, Dentler J, Luttmann W, et al., Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction., Clin Immunol. 2010 Oct; 137(1):89-101. doi: 10.1016/j.clim.2010.06.017 PMID: 20674506
19. Kuwano K, Hagimoto N, Nakanishi Y., The role of apoptosis in pulmonary fibrosis., Histol Histopathol. 2004 Jul; 19(3):867-881. PMID: 15168350
20. Sakai N, Tager AM., Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis., Biochim Biophys Acta. 2013 Jul; 1832(7):911-921. doi: 10.1016/j.bbadis.2013.03.001 PMID: 23499992
21. Redente EF, Keith RC, Janssen W, Henson PM, Ortiz LA, Downey GP, et al., Tumor necrosis factoralpha accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages., Am J RespirCell Mol Biol. 2014 Apr; 50(4):825-837. doi: 10.1165/rcmb.2013-0386OC PMID: 24325577
22. Clarke DL, Carruthers AM, Mustelin T, Murray LA., Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes., Fibrogenesis Tissue Repair. 2013;6(1):20. doi: 10.1186/1755-1536-6-20 PMID: 24279676
23. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A., IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis., Nat Med. 2006 Jan; 12(1):99-106. doi: 10.1038/nm1332 PMID: 16327802
24. Jakubzick C, Choi ES, Joshi BH, Keane MP, Kunkel SL, Puri RK, et al., Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsivecells., J Immunol. 2003 Sep; 171(5):2684-2693. doi: 10.4049/jimmunol.171.5.2684 PMID: 12928422
25. Vasakova M, Striz I, Slavcev A, Jandova S, Kolesar L, Sulc J., Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis., Tissue Antigens. 2006 Mar; 67(3):229-232. doi: 10.1111/j.1399-0039.2006.00560.x PMID: 16573560
26. Gharib SA, Johnston LK, Huizar I, Birkland TP, Hanson J, Wang Y, et al., MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis., J LeukocBiol. 2014 Jan; 95(1):9-18. doi: 10.1189/jlb.1112587 PMID: 23964118
27. Lomas NJ, Watts KL, Akram KM, Forsyth NR, Spiteri MA., Idiopathic pulmonary fibrosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers., Int J Clin Exp Pathol. 2012;5(1):58-71. PMID: 22295148
28. Murray LA, Chen Q, Kramer MS, Hesson DP, Argentieri RL, Peng X, et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P., Int J Biochem Cell Biol., 2011 Jan; 43(1):154-162. doi: 10.1016/j.biocel.2010.10.013
29. Tatler AL, Jenkins G. TGF-beta activation and lung fibrosis., ProcAmThoracSoc., 2012 Jul; 9(3):130-136. doi: 10.1513/pats.201201-003AW PMID: 22802287
30. Xiao L, Du Y, Shen Y, He Y, Zhao H, Li Z., TGF-beta1 induced fibroblast proliferation is mediated by the FGF-2/ERK pathway., Front Biosci (Landmark Ed). 2012;17:2667-2674. doi: 10.2741/4077
31. Ulrich D, Ulrich F, Unglaub F, Piatkowski A, Pallua N., Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids., J Plast ReconstrAesthetSurg. 2010 Jun; 63(6):1015-1021. doi: 10.1016/j.bjps.2009.04.021 PMID: 19464975
32. Hao W, Rovin BH, Friedman A., Mathematical model of renal interstitial fibrosis., Proc Natl Acad Sci USA. 2014 Sep; 111(39):14193-14198. doi: 10.1073/pnas.1413970111 PMID: 25225370
33. Ochs M, Nyengaard JR, Jung A, Knudsen L, Voigt M, Wahlers T, et al., The number of alveoli in the human lung., Am J RespirCritCare Med. 2004 Jan; 169(1):120-124. doi: 10.1164/rccm.200308-1107OC
34. Xue C, Friedman A, Sen CK., A mathematical model of ischemic cutaneous wounds., Proc Natl Acad Sci USA. 2009 Sep; 106(39):16782-16787. doi: 10.1073/pnas.0909115106 PMID: 19805373
35. Park SW, Ahn MH, Jang HK, Jang AS, Kim DJ, Koh ES, et al., Interleukin-13andits receptors in idiopathic interstitial pneumonia: clinical implications for lung function., J Korean Med Sci. 2009 Aug; 24(4):614-620. doi: 10.3346/jkms.2009.24.4.614 PMID: 19654941
36. Orbe J, Rodriguez JA, Arias R, Belzunce M, Nespereira B, Perez-Ilzarbe M, et al., Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization., Atherosclerosis. 2003 Mar; 167(1):45-53. doi: 10.1016/S0021-9150 (02) 00392-1 PMID: 12618267
37. Mann CJ, Perdiguero E, Kharraz Y, Aguilar S, Pessina P, Serrano AL, et al., Aberrant repair and fibrosis development in skeletal muscle., Skelet Muscle. 2011;1(1):21. doi: 10.1186/2044-5040-1-21 PMID: 21798099
38. Jikov VV, Kozlov SM, Oleinik OA., Homogenization of differential operators and integral functionals., Springer-Verlag. 1994;.
39. Crouser ED, Culver DA, Knox KS, Julian MW, Shao G, Abraham S, et al., Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis., Am J RespirCrit Care Med. 2009 May; 179(10):929-938. doi: 10.1164/rccm.200803-490OC PMID: 19218196
40. Hao W, Crouser ED, Friedman A., Mathematical model of sarcoidosis., Proc Natl Acad Sci USA. 2014 Nov; 111(45):16065-16070. doi: 10.1073/pnas.1417789111 PMID: 25349384
41. Nkyimbeng T, Ruppert C, Shiomi T, Dahal B, Lang G, Seeger W, et al., Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis., PLoS ONE. 2013;8(9):e73279. doi: 10.1371/journal.pone.0073279 PMID: 24023851
42. Bergeron A, Soler P, Kambouchner M, Loiseau P, Milleron B, Valeyre D, et al., Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10., Eur RespirJ. 2003 Jul; 22(1):69-76. doi: 10.1183/09031936.03.00014703 PMID: 12882453
43. Cho JH, Gelinas R, Wang K, Etheridge A, Piper MG, Batte K, et al., Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes., BMC Med Genomics. 2011;4:8. doi: 10.1186/1755-8794-4-8 PMID: 21241464
44. Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, et al., Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial., Am J Respir Crit Care Med. 2008 Nov; 178(9):948-955. doi: 10.1164/rccm.200709-1446OC PMID: 18669816
45. Daniels CE, Lasky JA, Limper AH, Mieras K, Gabor E, Schroeder DR, et al., Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results., Am J Respir Crit Care Med. 2010 Mar; 181(6):604-610. doi: 10.1164/rccm.200906-0964OC PMID: 20007927
46. Takeda Y, Tsujino K, Kijima T, Kumanogoh A., Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis., Patient Prefer Adherence. 2014;8:361-370. doi: 10.2147/PPA. S37233 PMID: 24711695
47. Sanders YY, Ambalavanan N, Halloran B, Zhang X, Liu H, et al., Altered DNA methylation profile in idiopathic pulmonary fibrosis., Am J Respir Crit Care Med. 2012 Sep; 186(6):525-535. doi: 10.1164/rccm. 201201-0077OC PMID: 22700861
48. Rabinovich EI, Kapetanaki MG, Steinfeld I, Gibson KF, Pandit KV, Yu G, et al., Global methylation patterns in idiopathic pulmonary fibrosis., PLoSONE. 2012;7(4):e33770. doi: 10.1371/journal.pone. 0033770 PMID: 22506007
49. Yang IV, Schwartz DA., Epigenetics of idiopathic pulmonary fibrosis., Transl Res. 2015 Jan; 165(1):48-60. doi: 10.1016/j.trsl.2014.03.011 PMID: 24746870
50. Nogee LM, Dunbar AE, Wert S, Askin F, Hamvas A, Whitsett JA., Mutations in the surfactant protein C gene associated with interstitial lung disease., Chest. 2002 Mar; 121(3 Suppl):20S-21S. doi: 10.1378/chest.121.3 suppl.20S PMID: 11893657
51. Whittington HA, Freeburn RW, Godinho SI, Egan J, Haider Y, Millar AB., Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis., Genes Immun. 2003 Jun; 4(4):258-264. doi: 10.1038/sj.gene. 6363959 PMID: 12761561
52. Vasakova M, Sterclova M, Matej R, Olejar T, Kolesar L, Skibova J, et al., IL-4 polymorphisms, HRCT score and lung tissue markers in idiopathic pulmonary fibrosis., Hum Immunol. 2013 Oct; 74(10):1346-1351. doi: 10.1016/j.humimm.2013.07.011 PMID: 23911740
53. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, et al., A common MUC5B promoter polymorphism and pulmonary fibrosis., N Engl J Med. 2011 Apr; 364(16):1503-1512. doi: 10.1056/NEJMoa1013660 PMID: 21506741
54. Armanios M., Telomerase mutations and the pulmonary fibrosis-bone marrow failure syndrome complex., N EnglJ Med. 2012 Jul; 367(4):384; author reply 384. doi: 10.1056/NEJMc1206730 PMID: 22830481
55. Hao W, Friedman A., The LDL-HDL Profile Determines the Risk of Atherosclerosis: A Mathematical Model., PLoSONE. 2014;9(3):e90497. doi: 10.1371/journal.pone.0090497 PMID: 24621857
56. Day J, Friedman A, Schlesinger LS., Modeling the immune rheostat of macrophages in the lung in response to infection., Proc Natl Acad Sci USA. 2009 Jul; 106(27):11246-11251. doi: 10.1073/pnas. 0904846106 PMID: 19549875
57. Alleva DG, Burger CJ, Elgert KD., Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production., Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2. J Immunol. 1994 Aug; 153(4):1674-1686. PMID: 8046239
58. Murphy J, Summer R, Wilson AA, Kotton DN, Fine A., The prolonged life-span of alveolar macrophages., Am J RespirCell Mol Biol. 2008 Apr; 38(4):380-385. doi: 10.1165/rcmb.2007-0224RC PMID: 18192503
59. Oliver JC, Bland LA, Oettinger CW, Arduino MJ, McAllister SK, Aguero SM, et al., Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge., Lymphokine Cytokine Res. 1993 Apr; 12(2):115-120. PMID: 8324076